X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs BIOCON LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD BIOCON LTD MERCK LTD/
BIOCON LTD
 
P/E (TTM) x 25.9 36.6 70.8% View Chart
P/BV x 2.9 4.9 59.6% View Chart
Dividend Yield % 1.0 1.5 64.1%  

Financials

 MERCK LTD   BIOCON LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-16
BIOCON LTD
Mar-16
MERCK LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,060496 213.8%   
Low Rs623397 157.1%   
Sales per share (Unadj.) Rs632.4174.3 362.9%  
Earnings per share (Unadj.) Rs45.744.8 102.0%  
Cash flow per share (Unadj.) Rs62.356.9 109.5%  
Dividends per share (Unadj.) Rs11.005.00 220.0%  
Dividend yield (eoy) %1.31.1 116.6%  
Book value per share (Unadj.) Rs388.8202.8 191.8%  
Shares outstanding (eoy) m16.60200.00 8.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.32.6 52.0%   
Avg P/E ratio x18.410.0 184.9%  
P/CF ratio (eoy) x13.57.8 172.3%  
Price / Book Value ratio x2.22.2 98.4%  
Dividend payout %24.111.2 215.6%   
Avg Mkt Cap Rs m13,96989,220 15.7%   
No. of employees `0001.64.4 35.9%   
Total wages/salary Rs m1,4876,363 23.4%   
Avg. sales/employee Rs Th6,631.97,894.5 84.0%   
Avg. wages/employee Rs Th939.21,441.2 65.2%   
Avg. net profit/employee Rs Th479.42,029.7 23.6%   
INCOME DATA
Net Sales Rs m10,49834,854 30.1%  
Other income Rs m242845 28.7%   
Total revenues Rs m10,74135,699 30.1%   
Gross profit Rs m1,1358,200 13.8%  
Depreciation Rs m2762,423 11.4%   
Interest Rs m0102 0.0%   
Profit before tax Rs m1,1026,520 16.9%   
Minority Interest Rs m0-744 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m05,754 0.0%   
Tax Rs m3432,569 13.4%   
Profit after tax Rs m7598,961 8.5%  
Gross profit margin %10.823.5 46.0%  
Effective tax rate %31.139.4 79.0%   
Net profit margin %7.225.7 28.1%  
BALANCE SHEET DATA
Current assets Rs m6,41039,932 16.1%   
Current liabilities Rs m8,82816,276 54.2%   
Net working cap to sales %-23.067.9 -33.9%  
Current ratio x0.72.5 29.6%  
Inventory Days Days5854 107.7%  
Debtors Days Days3886 44.5%  
Net fixed assets Rs m1,40639,101 3.6%   
Share capital Rs m1661,000 16.6%   
"Free" reserves Rs m6,28638,591 16.3%   
Net worth Rs m6,45540,556 15.9%   
Long term debt Rs m020,724 0.0%   
Total assets Rs m8,82884,816 10.4%  
Interest coverage xNM64.9-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 289.4%   
Return on assets %8.610.7 80.4%  
Return on equity %11.822.1 53.2%  
Return on capital %17.119.0 90.0%  
Exports to sales %8.330.7 26.9%   
Imports to sales %21.020.4 103.2%   
Exports (fob) Rs m86910,717 8.1%   
Imports (cif) Rs m2,2097,105 31.1%   
Fx inflow Rs m95911,789 8.1%   
Fx outflow Rs m2,6128,393 31.1%   
Net fx Rs m-1,6533,396 -48.7%   
CASH FLOW
From Operations Rs m1,0705,264 20.3%  
From Investments Rs m-750-9,540 7.9%  
From Financial Activity Rs m-15010,867 -1.4%  
Net Cashflow Rs m1716,591 2.6%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.8 20.6 251.5%  
Indian inst/Mut Fund % 18.2 8.4 216.7%  
FIIs % 1.0 10.7 9.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 19.9 146.2%  
Shareholders   28,591 109,995 26.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   DR. DATSONS LABS  STRIDES SHASUN LTD  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ABBOTT INDIA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS